BioMed Research International

BioMed Research International / 2020 / Article

Erratum | Open Access

Volume 2020 |Article ID 1892431 | https://doi.org/10.1155/2020/1892431

Jie Shu, Wei Liu, Fei Han, Fanyan Luo, "Erratum to “Trimethoxystilbene Reduces Nuclear Factor Kappa B, Interleukin-6, and Tumor Necrosis Factor-α Levels in Rats with Pulmonary Artery Hypertension”", BioMed Research International, vol. 2020, Article ID 1892431, 1 page, 2020. https://doi.org/10.1155/2020/1892431

Erratum to “Trimethoxystilbene Reduces Nuclear Factor Kappa B, Interleukin-6, and Tumor Necrosis Factor-α Levels in Rats with Pulmonary Artery Hypertension”

Received09 Jul 2020
Accepted10 Jul 2020
Published11 Sep 2020

In the article titled “Trimethoxystilbene Reduces Nuclear Factor Kappa B, Interleukin-6, and Tumor Necrosis Factor-α Levels in Rats with Pulmonary Artery Hypertension” [1], information was omitted in the Authors’ Contributions section. The corrected section appears below:

Authors’ Contributions

Jie Shu and Wei Liu are joint first co-authors.

References

  1. J. Shu, W. Liu, F. Han, and F. Luo, “Trimethoxystilbene reduces nuclear factor kappa B, interleukin-6, and tumor necrosis Factor-α Levels in rats with pulmonary artery hypertension,” BioMed Research International, vol. 2019, Article ID 1219848, 8 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2020 Jie Shu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views40
Downloads38
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.